NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Formats Text Remove constraint Formats: Text Subjects United States. Department of Health and Human Services. Remove constraint Subjects: United States. Department of Health and Human Services. Subjects United States. Food and Drug Administration. Remove constraint Subjects: United States. Food and Drug Administration.

Search Results

261. Oncology pharmaceuticals: reproductive toxicity testing and labeling recommendations

262. Considerations in demonstrating interchangeability with a reference product

263. FDA deems certain tobacco products subject to FDA authority, sales and distribution restrictions, and health warning requirements for packages and advertisements: (revised)

264. Extension of certain tobacco product compliance deadlines related to the final deeming rule: (revised)

265. Interpretation of and compliance policy for certain label requirement: applicability of certain Federal Food, Drug, and Cosmetic Act requirements to vape shops

266. Premarket tobacco product applications for electronic nicotine delivery systems

267. Marketing clearance of diagnostic ultrasound systems and transducers: guidance for industry and Food and Drug Administration staff

269. Compliance policy for certain compounding of oral oxitriptan (5-HTP) drug products for patients with tetrahydrobiopterin (BH4) deficiency: immediately in effect guidance for industry

270. Delayed graft function in kidney transplantation: developing drugs for prevention